AI Verdict
AMGN has stronger fundamentals based on our AI analysis.
ABBV vs AMGN Fundamental Comparison
| Metric | ABBV | AMGN |
|---|---|---|
| Revenue | $61.2B | $36.8B |
| Net Income | $4.2B | $7.7B |
| Net Margin | 6.9% | 21.0% |
| ROE | N/A | 89.1% |
| ROA | 3.2% | 8.5% |
| Current Ratio | 0.67x | 1.14x |
| Debt/Equity | N/A | 6.31x |
| EPS | $2.36 | $14.23 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ABBV vs AMGN: Frequently Asked Questions
Is ABBV or AMGN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), AMGN has stronger fundamentals. ABBV is rated HOLD (70% confidence) while AMGN is rated BUY (84% confidence). This is not investment advice.
How does ABBV compare to AMGN fundamentally?
AbbVie Inc. has ROE of N/A vs AMGEN INC's 89.1%. Net margins are 6.9% vs 21.0% respectively.
Which stock pays higher dividends, ABBV or AMGN?
ABBV has a dividend yield of N/A or no dividend while AMGN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ABBV or AMGN for long term?
For long-term investing, consider that ABBV has HOLD rating with 70% confidence, while AMGN has BUY rating with 84% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ABBV vs AMGN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABBV vs AMGN, the AI consensus favors AMGN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.